Insulet
PODD
£205.28
Share price
7.16%
Change (1 day)
46.20%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
P/S ratio for Insulet (PODD)
P/S ratio as of April 2025 (TTM): 8.97
According to Insulet's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.3. At the end of 2024 the company had a P/S ratio of 8.98.
P/S ratio history for Insulet from 2007 to 2024
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2024 | 8.98 | 0.55% |
| 2023 | 8.93 | -43% |
| 2022 | 15.7 | -6.21% |
| 2021 | 16.7 | -10.38% |
| 2020 | 18.6 | 28.18% |
| 2019 | 14.5 | 74.59% |
| 2018 | 8.33 | -3.82% |
| 2017 | 8.66 | 46.83% |
| 2016 | 5.90 | -23.28% |
| 2015 | 7.69 | -14.43% |
| 2014 | 8.98 | 9.01% |
| 2013 | 8.24 | 69.7% |
| 2012 | 4.85 | -17.17% |
| 2011 | 5.86 | -19.31% |
| 2010 | 7.26 | -11.04% |
| 2009 | 8.16 | 48.78% |
| 2008 | 5.49 | -87.81% |
| 2007 | 45.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 1.56 | -82.61% | 🇺🇸 USA |
 | 1.28 | -85.73% | 🇺🇸 USA |
 | 6.50 | -27.58% | 🇺🇸 USA |
 | 4.10 | -54.36% | 🇺🇸 USA |
 | 5.25 | -41.47% | 🇺🇸 USA |
 | 3.29 | -63.29% | 🇮🇪 Ireland |
 | 15.0 | 67.45% | 🇺🇸 USA |